Your browser doesn't support javascript.
loading
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial.
Tabarsi, Payam; Anjidani, Nassim; Shahpari, Ramin; Mardani, Masoud; Sabzvari, Araz; Yazdani, Babak; Kafi, Hamidreza; Fallah, Newsha; Ebrahimi, Ali; Taheri, Ali; Petrovsky, Nikolai; Barati, Saghar.
Afiliação
  • Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute for Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Anjidani N; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Shahpari R; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Mardani M; Infectious Disease and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sabzvari A; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Yazdani B; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Kafi H; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Fallah N; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Ebrahimi A; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Taheri A; Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Petrovsky N; Vaxine Pty Ltd, Bedford Park, Adelaide Australia.
  • Barati S; Medical Department, Orchid Pharmed Company, Tehran, Iran. Electronic address: Barati.S@orchidpharmed.com.
Clin Microbiol Infect ; 29(2): 215-220, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36096430
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã